drugset / Trial / NCT00347815
Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the amount of buprenorphine and its metabolites in blood and urine after administration of 0.6 mg buprenorphine in healthy volunteers. Furthermore the purpose is to correlate the amount of buprenorphine in the blood with the effect on the ability to concentrate and coordinate.
Timeline
- Start
- 2006-06
- Primary completion
- —
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 0.6 mg | Intravenous |
Indications
No indication recorded.